Global Diabetes Market Report: 2013 Edition
Diabetes is a group of metabolic diseases in which the person has high blood glucose (blood sugar) either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. Prediabetes happens when a person's blood glucose levels are higher than normal but not high enough to be type 2 diabetes. Type 1 diabetes, Type 2 diabetes and Gestational diabetes are the three types of diabetes. There are mainly three types of diabetes treatment which include insulin, oral antidiabetic drug (OAD) and glucagon-like-peptide-1 (GLP-1).
The report examines the diabetes market on a global scale and its various segments and also provides detailed information regarding the key regional markets. The region that has the largest diabetic population is Western Pacific followed by South East Asia and other regions. In terms of prevalence rate, the largest region is Middle East and North Africa accompanied by North America and Caribbean. Europe is the market leader in the insulin market worldwide whereas North America accounts for the largest share in the global GLP-1 market.
The competition in the global diabetes market is intense with few large players viz. Novo Nordisk, Takeda, Sanofi-Aventis and Eli Lilly. The competitive landscape of the global and regional diabetes markets, along with the company profiles of the leading players are discussed in detail.
The major growth drivers observed within the industry include increasing ageing population since older people are more likely to have insulin resistance, increasing urbanization, rising obese population and growing healthcare expenditure. However, the industry remains threatened by certain challenges which include high diabetes cost which is a huge burden for families.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
The report examines the diabetes market on a global scale and its various segments and also provides detailed information regarding the key regional markets. The region that has the largest diabetic population is Western Pacific followed by South East Asia and other regions. In terms of prevalence rate, the largest region is Middle East and North Africa accompanied by North America and Caribbean. Europe is the market leader in the insulin market worldwide whereas North America accounts for the largest share in the global GLP-1 market.
The competition in the global diabetes market is intense with few large players viz. Novo Nordisk, Takeda, Sanofi-Aventis and Eli Lilly. The competitive landscape of the global and regional diabetes markets, along with the company profiles of the leading players are discussed in detail.
The major growth drivers observed within the industry include increasing ageing population since older people are more likely to have insulin resistance, increasing urbanization, rising obese population and growing healthcare expenditure. However, the industry remains threatened by certain challenges which include high diabetes cost which is a huge burden for families.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. INTRODUCTION TO DIABETES
Types of Diabetes
Symptoms
Risk Factors
Diagnosis
Treatment
2. GLOBAL DIABETES MARKET
Diabetic Population Growth
Regional Breakdown
Prevalence Rate
Market Revenues
Market Segmentation
Insulin Market
Major DPP-4 Drugs
3. REGIONAL ANALYSIS
3.1 The Western Pacific
Market Overview
Regional Breakdown
3.1.1 China
Market Overview
Prevalence Rate
Insulin Market
3.1.2 Japan
Market Overview
Insulin Market
3.2.3 Other Countries
3.2 South-East Asia
Market Overview
Regional Breakdown
3.2.1 India
Market Overview
Prevalence Rate
3.2.2 Other Countries
3.3 Europe
Market Overview
Regional Breakdown
Insulin Market
3.3.1 United Kingdom
Market Overview
Regional Breakdown
Prevalence Rate
3.3.2 Other Countries
3.4 North America and Caribbean
Market Overview
Regional Breakdown
3.4.1 The US
Market Overview
Market Value
Insulin Market
DPP-4 Market
3.4.2 Other Countries
3.5 Middle East and North Africa
Market Overview
Regional Breakdown
3.5.1 Other Countries
3.6 South and Central America
Market Overview
Regional Breakdown
3.6.1 Latin America
3.6.1 Other Countries
3.7 Africa
Market Overview
Regional Breakdown
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Increasing Aging Population
4.1.2 Increasing Urbanization
4.1.3 Rising Obese Population
4.1.4 Rising Healthcare Expenditure
4.2 Challenges
4.2.1 Diabetes Cost - A Burden for Family and Society
4.2.3 Effective Management of Diabetes
5. COMPETITIVE LANDSCAPE
5.1 Global
Overall Market Share
Insulin Market Share
Modern Insulin Share
Insulin Analogues Share
Insulin Pump Share
5.2 Americas
5.2.1 The US
5.2.2 Latin America
5.3 Europe
5.4 Asia
5.4.1 India
5.4.2 China
5.4.3 Japan
5.5 Rest of the World
6. COMPANY PROFILE
6.1 Novo Nordisk
6.1.1 Business Description
6.1.2 Financial Highlights
6.1.3 Business Strategies
Product Innovation
6.2 Takeda
6.2.1 Business Description
6.2.2 Financial Highlights
6.2.3 Business Strategies
Market Expansion through Acquisitions
Product Innovation
6.3 Sanofi-Aventis
6.3.1 Business Description
6.3.2 Financial Highlights
6.3.3 Business Strategies
Acquisition Policy
Bringing Innovative Products to Market
6.4 Eli Lilly
6.4.1 Business Description
6.4.2 Financial Highlights
6.4.3 Business Strategies
Strategic Acquisitions
Undertaking Research and Development
7. MARKET OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
Types of Diabetes
Symptoms
Risk Factors
Diagnosis
Treatment
2. GLOBAL DIABETES MARKET
Diabetic Population Growth
Regional Breakdown
Prevalence Rate
Market Revenues
Market Segmentation
Insulin Market
Major DPP-4 Drugs
3. REGIONAL ANALYSIS
3.1 The Western Pacific
Market Overview
Regional Breakdown
3.1.1 China
Market Overview
Prevalence Rate
Insulin Market
3.1.2 Japan
Market Overview
Insulin Market
3.2.3 Other Countries
3.2 South-East Asia
Market Overview
Regional Breakdown
3.2.1 India
Market Overview
Prevalence Rate
3.2.2 Other Countries
3.3 Europe
Market Overview
Regional Breakdown
Insulin Market
3.3.1 United Kingdom
Market Overview
Regional Breakdown
Prevalence Rate
3.3.2 Other Countries
3.4 North America and Caribbean
Market Overview
Regional Breakdown
3.4.1 The US
Market Overview
Market Value
Insulin Market
DPP-4 Market
3.4.2 Other Countries
3.5 Middle East and North Africa
Market Overview
Regional Breakdown
3.5.1 Other Countries
3.6 South and Central America
Market Overview
Regional Breakdown
3.6.1 Latin America
3.6.1 Other Countries
3.7 Africa
Market Overview
Regional Breakdown
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Increasing Aging Population
4.1.2 Increasing Urbanization
4.1.3 Rising Obese Population
4.1.4 Rising Healthcare Expenditure
4.2 Challenges
4.2.1 Diabetes Cost - A Burden for Family and Society
4.2.3 Effective Management of Diabetes
5. COMPETITIVE LANDSCAPE
5.1 Global
Overall Market Share
Insulin Market Share
Modern Insulin Share
Insulin Analogues Share
Insulin Pump Share
5.2 Americas
5.2.1 The US
5.2.2 Latin America
5.3 Europe
5.4 Asia
5.4.1 India
5.4.2 China
5.4.3 Japan
5.5 Rest of the World
6. COMPANY PROFILE
6.1 Novo Nordisk
6.1.1 Business Description
6.1.2 Financial Highlights
6.1.3 Business Strategies
Product Innovation
6.2 Takeda
6.2.1 Business Description
6.2.2 Financial Highlights
6.2.3 Business Strategies
Market Expansion through Acquisitions
Product Innovation
6.3 Sanofi-Aventis
6.3.1 Business Description
6.3.2 Financial Highlights
6.3.3 Business Strategies
Acquisition Policy
Bringing Innovative Products to Market
6.4 Eli Lilly
6.4.1 Business Description
6.4.2 Financial Highlights
6.4.3 Business Strategies
Strategic Acquisitions
Undertaking Research and Development
7. MARKET OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
LIST OF CHARTS
Types of Diabetes
Global Diabetic Population (2004-2012)
Global Diabetes Population by Geographical Segments (2012)
Global Diabetes Prevalence Rates (2012)
Global Diabetes Market Revenues (2008-2012E)
Diabetes Market by Treatment Product (2012)
Global Diabetes Market Revenues by Class (2008-2012E)
Global Insulin Volumes in tMU (2005-2011)
Global Insulin Market by Segments (2012)
Global Insulin Market by Geographical Segments (2012)
Global Insulin Analog Market (2007-2012E)
Global revenues of major DPP-4 line Drugs (2008-2011)
Global GLP-1 Market by Geographical Segments (2012)
Top Countries by Diabetes Case in Western Pacific (2012)
Number of cases with diabetes among Chinese adults (>20 years of age) (2012)
Prevalence of Diabetes among Chinese Adults 20 Years of Age or Older (2012)
Prevalence of Diabetes and Prediabetes by Body Mass Index in Chinese Population (2012)
Market Scale of Diabetes Medicines in China (2004-2011)
Insulin Medicine Market in China (2006-2011)
Import Value of Insulin and Insulin Salts and YoY Growth Rate in China (2008-2011)
Chinese Insulin Market by Segments (2012)
Japanese Insulin Market by Segments (2012)
Top Countries by Diabetes Case in South East Asia (2012)
Prevalence of Diabetes and Pre Diabetes in India by age (2011)
Top 10 Countries by Diabetes cases (2012)
European Insulin market by Segments (2012)
Number of people recorded with diabetes in Scotland (2001 – 2011)
Types of Diabetes in Scotland (2011)
Top Countries by Diabetes Case in North America and Caribbean (2012)
US Diabetic Market in Value (2006-2011)
US Insulin Market by Segment (2012)
US Oral DPP-4 Inhibitors Market Share (2012)
DPP-4 Share of Oral Diabetes Market (2007-2012E)
Top Countries by Diabetes Case in Middle East and North Africa (2012)
Top Countries by Diabetes Case in South and Central America (2012)
Insulin Market by Type in Latin America (2012)
Top Countries by Diabetes Case in Africa (2012)
Global Ageing Population (2005-2013F)
Global Urban Population (2005-2011)
Growth in Worldwide Obese Population (2004-2012F)
Healthcare Expenditure Worldwide (2005-2012E)
Global Diabetes Market Share by Company (2012)
Global Insulin Market Share by Value (2011)
Global Modern Insulin Market Share by Volume (2012)
Global Insulin Analogues Market Share by Volume (2011)
Global Blood Glucose Testing Market Share (2011)
Global Insulin Pump Market Share (2012)
Modern Insulin Market Share in the US by Value (2012)
United States Insulin Market Share by value and by volume (2011)
Diabetes Market Share in Latin America (2012)
Modern Insulin Market Share in Western Europe by Value (2012)
Insulin Market Share In India (2012)
Human Insulin Market Share in India (2011)
Modern Insulin Market Share In China (2012)
Modern Insulin Market Share In Japan (2012)
Insulin Market Share in Rest of the World by Value (2011)
Novo Nordisk’s Revenue Share by Business Segments (2012)
Novo Nordisk’s Revenue Share by Region (2012)
Sales and Net Income of Novo-Nordisk (2008-2012)
Takeda’s Revenue Share by Business Segments (2012)
Takeda’s Revenue Share by Region (2012)
Revenues and Net Income of Takeda (2008-2012)
Sanofi-Aventis’s Revenue Share by Business Segment (2012)
Sanofi-Aventis’s Revenue Share by Region (2012)
Revenues and Net Income of Sanofi-Aventis (2008-2012)
Eli Lilly’s Revenue Share by Business Segments (2012)
Eli Lilly’s Revenue Share by Region (2012)
Revenue and Net Income of Eli Lilly (2008-2012)
Global Diabetic Population (2011-2016F)
Types of Diabetes
Global Diabetic Population (2004-2012)
Global Diabetes Population by Geographical Segments (2012)
Global Diabetes Prevalence Rates (2012)
Global Diabetes Market Revenues (2008-2012E)
Diabetes Market by Treatment Product (2012)
Global Diabetes Market Revenues by Class (2008-2012E)
Global Insulin Volumes in tMU (2005-2011)
Global Insulin Market by Segments (2012)
Global Insulin Market by Geographical Segments (2012)
Global Insulin Analog Market (2007-2012E)
Global revenues of major DPP-4 line Drugs (2008-2011)
Global GLP-1 Market by Geographical Segments (2012)
Top Countries by Diabetes Case in Western Pacific (2012)
Number of cases with diabetes among Chinese adults (>20 years of age) (2012)
Prevalence of Diabetes among Chinese Adults 20 Years of Age or Older (2012)
Prevalence of Diabetes and Prediabetes by Body Mass Index in Chinese Population (2012)
Market Scale of Diabetes Medicines in China (2004-2011)
Insulin Medicine Market in China (2006-2011)
Import Value of Insulin and Insulin Salts and YoY Growth Rate in China (2008-2011)
Chinese Insulin Market by Segments (2012)
Japanese Insulin Market by Segments (2012)
Top Countries by Diabetes Case in South East Asia (2012)
Prevalence of Diabetes and Pre Diabetes in India by age (2011)
Top 10 Countries by Diabetes cases (2012)
European Insulin market by Segments (2012)
Number of people recorded with diabetes in Scotland (2001 – 2011)
Types of Diabetes in Scotland (2011)
Top Countries by Diabetes Case in North America and Caribbean (2012)
US Diabetic Market in Value (2006-2011)
US Insulin Market by Segment (2012)
US Oral DPP-4 Inhibitors Market Share (2012)
DPP-4 Share of Oral Diabetes Market (2007-2012E)
Top Countries by Diabetes Case in Middle East and North Africa (2012)
Top Countries by Diabetes Case in South and Central America (2012)
Insulin Market by Type in Latin America (2012)
Top Countries by Diabetes Case in Africa (2012)
Global Ageing Population (2005-2013F)
Global Urban Population (2005-2011)
Growth in Worldwide Obese Population (2004-2012F)
Healthcare Expenditure Worldwide (2005-2012E)
Global Diabetes Market Share by Company (2012)
Global Insulin Market Share by Value (2011)
Global Modern Insulin Market Share by Volume (2012)
Global Insulin Analogues Market Share by Volume (2011)
Global Blood Glucose Testing Market Share (2011)
Global Insulin Pump Market Share (2012)
Modern Insulin Market Share in the US by Value (2012)
United States Insulin Market Share by value and by volume (2011)
Diabetes Market Share in Latin America (2012)
Modern Insulin Market Share in Western Europe by Value (2012)
Insulin Market Share In India (2012)
Human Insulin Market Share in India (2011)
Modern Insulin Market Share In China (2012)
Modern Insulin Market Share In Japan (2012)
Insulin Market Share in Rest of the World by Value (2011)
Novo Nordisk’s Revenue Share by Business Segments (2012)
Novo Nordisk’s Revenue Share by Region (2012)
Sales and Net Income of Novo-Nordisk (2008-2012)
Takeda’s Revenue Share by Business Segments (2012)
Takeda’s Revenue Share by Region (2012)
Revenues and Net Income of Takeda (2008-2012)
Sanofi-Aventis’s Revenue Share by Business Segment (2012)
Sanofi-Aventis’s Revenue Share by Region (2012)
Revenues and Net Income of Sanofi-Aventis (2008-2012)
Eli Lilly’s Revenue Share by Business Segments (2012)
Eli Lilly’s Revenue Share by Region (2012)
Revenue and Net Income of Eli Lilly (2008-2012)
Global Diabetic Population (2011-2016F)
LIST OF TABLES
Diabetes Market in Western Pacific (2012)
Diabetes in China (2012)
Diabetes in Japan (2012)
Diabetes in other countries of Western Pacific (2012)
Diabetes Market in South-East Asia (2012)
Diabetes in India (2012)
Diabetes in other countries of South East Asia (2012)
Diabetes Market in Europe (2012)
Diabetes in United Kingdom (2012)
Diabetes in UK – Regional analysis (2011)
Prevalence of diabetes by age group, sex and ethnicity in England (2012)
Diabetes prevalence in Wales by diabetes type (2012)
Age group of people recorded with type 1 and type 2 diabetes and percentage in each age group by diabetes type in Scotland (2011)
Number of new Cases (per 100,000 populations per year) of type 1 diabetes by age in Scotland (2008-2011)
Number of new Cases (per 100,000 populations per year) of type 2 diabetes by age in Scotland (2008-2011)
Diabetes in other countries of Europe (2012)
Diabetes Market in North America and Caribbean (2012)
Diabetes in the US (2010-2013E)
Diabetes in other countries of the North American and Caribbean region (2012)
Diabetes Market in Middle East and North Africa (2012)
Diabetes in other countries of the Middle East and North Africa region (2012)
Diabetes Market in South and Central America (2012)
Diabetes in other countries of the South and Central America region (2012)
Diabetes Market in Africa (2012)
Dependent & Independent Variables (2007– 2012)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Diabetes Market in Western Pacific (2012)
Diabetes in China (2012)
Diabetes in Japan (2012)
Diabetes in other countries of Western Pacific (2012)
Diabetes Market in South-East Asia (2012)
Diabetes in India (2012)
Diabetes in other countries of South East Asia (2012)
Diabetes Market in Europe (2012)
Diabetes in United Kingdom (2012)
Diabetes in UK – Regional analysis (2011)
Prevalence of diabetes by age group, sex and ethnicity in England (2012)
Diabetes prevalence in Wales by diabetes type (2012)
Age group of people recorded with type 1 and type 2 diabetes and percentage in each age group by diabetes type in Scotland (2011)
Number of new Cases (per 100,000 populations per year) of type 1 diabetes by age in Scotland (2008-2011)
Number of new Cases (per 100,000 populations per year) of type 2 diabetes by age in Scotland (2008-2011)
Diabetes in other countries of Europe (2012)
Diabetes Market in North America and Caribbean (2012)
Diabetes in the US (2010-2013E)
Diabetes in other countries of the North American and Caribbean region (2012)
Diabetes Market in Middle East and North Africa (2012)
Diabetes in other countries of the Middle East and North Africa region (2012)
Diabetes Market in South and Central America (2012)
Diabetes in other countries of the South and Central America region (2012)
Diabetes Market in Africa (2012)
Dependent & Independent Variables (2007– 2012)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
